NICE has today (28 March) published a summary for healthcare professionals bringing together all its recommendations and other safety advice on the drug valproate.
28 March 2019
A promising new lung cancer treatment will be available on the NHS through the Cancer Drugs Fund, thanks to a new NICE recommendation.
28 March 2019
Organisation was founded in April 1999 to improve outcome for health service users
18 March 2019
NICE has published its draft updated guideline on the diagnosis and treatment of high blood pressure (hypertension) for public consultation.
11 March 2019
Hundreds more people with severe to profound deafness will be eligible for cochlear implants each year, due to updated NICE guidance
07 March 2019
The updated quality standard highlights that authorities should assess planning applications and consider how the effects of traffic-related air pollution may affect local communities.
28 February 2019
NICE says drug to treat Batten disease cannot be recommended for NHS use because company is unable to address concerns about long-term effectiveness
NICE has published draft guidance which confirms its earlier decision not to recommend cerliponase alfa (also called Brineura and made by Biomarin) for children with Batten disease – a very rare inherited condition affecting between 1 and 6 babies each year in the UK.
22 February 2019
Shared Learning Awards: Judges reveal 20 shortlisted entries to be displayed at NICE annual conference
More than 60 entries received from organisations across the country which highlight how they put NICE guidance into practice
21 February 2019
NICE draft guidance recommends pertuzumab for new breast cancer indication after improved price offer from company
NICE has published final draft guidance recommending pertuzumab (Perjeta, Roche) for treating early HER2-positive breast cancer in people whose disease has spread to their lymph nodes.
15 February 2019